Next Article in Journal
Roles of Copper-Binding Proteins in Breast Cancer
Next Article in Special Issue
Altered Adipogenesis in Zebrafish Larvae Following High Fat Diet and Chemical Exposure Is Visualised by Stimulated Raman Scattering Microscopy
Previous Article in Journal
Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction
Previous Article in Special Issue
Morphofunctional Alterations in Zebrafish (Danio rerio) Gills after Exposure to Mercury Chloride
Open AccessArticle

ZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish

1
ZeClinics SL, PRBB (Barcelona Biomedical Research Park), 08003 Barcelona, Spain
2
Pivot Park Screening Centre (PPSC), Kloosterstraat 9, 5349AB OSS, The Netherland
3
Multilevel Dynamics in Morphogenesis Unit, USR3695 CNRS, 91190 Gif sur Yvette, France
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Juliette Legler
Int. J. Mol. Sci. 2017, 18(4), 864; https://doi.org/10.3390/ijms18040864
Received: 1 March 2017 / Revised: 7 April 2017 / Accepted: 14 April 2017 / Published: 19 April 2017
(This article belongs to the Special Issue Zebrafish: A Model for Toxicological Research)
Toxicity is one of the major attrition causes during the drug development process. In that line, cardio-, neuro-, and hepatotoxicities are among the main reasons behind the retirement of drugs in clinical phases and post market withdrawal. Zebrafish exploitation in high-throughput drug screening is becoming an important tool to assess the toxicity and efficacy of novel drugs. This animal model has, from early developmental stages, fully functional organs from a physiological point of view. Thus, drug-induced organ-toxicity can be detected in larval stages, allowing a high predictive power on possible human drug-induced liabilities. Hence, zebrafish can bridge the gap between preclinical in vitro safety assays and rodent models in a fast and cost-effective manner. ZeGlobalTox is an innovative assay that sequentially integrates in vivo cardio-, neuro-, and hepatotoxicity assessment in the same animal, thus impacting strongly in the 3Rs principles. It Reduces, by up to a third, the number of animals required to assess toxicity in those organs. It Refines the drug toxicity evaluation through novel physiological parameters. Finally, it might allow the Replacement of classical species, such as rodents and larger mammals, thanks to its high predictivity (Specificity: 89%, Sensitivity: 68% and Accuracy: 78%). View Full-Text
Keywords: ZeGlobalTox; zebrafish; high-throughput; adverse drug reaction; drug toxicity; cardiotoxicity; neurotoxicity; hepatotoxicity ZeGlobalTox; zebrafish; high-throughput; adverse drug reaction; drug toxicity; cardiotoxicity; neurotoxicity; hepatotoxicity
Show Figures

Graphical abstract

MDPI and ACS Style

Cornet, C.; Calzolari, S.; Miñana-Prieto, R.; Dyballa, S.; Van Doornmalen, E.; Rutjes, H.; Savy, T.; D’Amico, D.; Terriente, J. ZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish. Int. J. Mol. Sci. 2017, 18, 864.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop